RCE.AX
Recce Pharmaceuticals Ltd
ASXAUDEQUITY
DELAYED
Last price
0.37
▼ 0.01 (2.67%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.38
Prev close
0.38
Day high
0.38
Day low
0.37
Volume
230.82K
Market cap
—
P/E (TTM)
—
52W range
0.35 – 0.73
Trailing performance
Returnvs SPY
1W
-1.35%
+0.0%
1M
+1.39%
-2.3%
3M
-27.72%
-30.8%
6M
-35.96%
-47.0%
YTD
-43.85%
-56.1%
1Y
-15.12%
-35.1%
3Y
-48.08%
-122.2%
5Y
-52.43%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on RCE.AX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Selling, general & admin | $9.52M | $6.74M | $5.23M | $3.37M | +41.2% |
| Total operating expense | $28.00M | $22.05M | $17.24M | $12.60M | +27.0% |
| Operating income | -$28.00M | -$22.05M | -$17.24M | -$12.60M | -27.0% |
| Net interest income | -$1.15M | -$659.85K | -$117.08K | $79.07K | -74.8% |
| Pre-tax income | -$21.43M | -$17.66M | -$13.08M | -$10.99M | -21.3% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$21.43M | -$17.66M | -$13.08M | -$10.99M | -21.3% |
| Net income to common | -$21.43M | -$17.66M | -$13.08M | -$10.99M | -21.3% |
| Basic EPS | -0.09 | -0.10 | -0.07 | -0.06 | +8.5% |
| Diluted EPS | -0.09 | -0.10 | -0.07 | -0.06 | +8.5% |
| EBIT | -$20.28M | -$16.86M | -$12.90M | -$10.98M | -20.3% |
| EBITDA | -$19.92M | -$16.49M | -$12.69M | -$10.80M | -20.8% |
| Basic shares | 236.98M | 178.80M | 177.40M | 177.56M | +32.5% |
| Diluted shares | 236.98M | 178.80M | 177.40M | 177.56M | +32.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $10.45M | $4.62M | $1.56M | $11.58M | +126.0% |
| Cash & short-term investments | $10.45M | $4.62M | $1.56M | $11.58M | +126.0% |
| Total current assets | $11.39M | $5.34M | $1.95M | $12.18M | +113.1% |
| Property, plant & equipment | $1.03M | $1.27M | $649.24K | $438.78K | -19.1% |
| Total assets | $12.41M | $6.62M | $2.60M | $12.62M | +87.6% |
| Total current liabilities | $6.13M | $15.07M | $4.85M | $2.45M | -59.3% |
| Current debt | $1.53M | — | — | — | — |
| Long-term debt | $8.60M | — | — | — | — |
| Total debt | $10.77M | $811.19K | $250.57K | $74.76K | +1,227.5% |
| Total liabilities | $15.47M | $15.89M | $5.14M | $2.56M | -2.7% |
| Retained earnings | -$91.50M | -$70.08M | -$55.54M | -$42.46M | -30.6% |
| Shareholder equity | -$3.05M | -$9.52M | -$2.59M | $10.06M | +68.0% |
| Working capital | $5.26M | -$9.73M | -$2.90M | $9.74M | +154.1% |
| Net tangible assets | -$3.05M | -$9.52M | -$2.59M | $10.06M | +68.0% |
| Shares issued | 288.37M | 205.95M | 181.76M | 181.14M | +40.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$26.35K | -$141.90K | -$38.63K | -$40.34K | +81.4% |
| Investing cash flow | -$443.90K | -$141.90K | -$38.63K | -$40.34K | -212.8% |
| Financing cash flow | $26.92M | $16.00M | $2.71M | -$240.50K | +68.2% |
| Free cash flow | -$20.47M | -$13.15M | -$12.73M | -$9.05M | -55.6% |
| End cash position | $10.45M | $4.42M | $1.56M | $11.58M | +136.7% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-06-30 | YoY |
|---|---|---|
| Cash & equivalents | $10.45M | |
| Cash & short-term investments | $10.45M | |
| Total current assets | $11.39M | |
| Property, plant & equipment | $1.03M | |
| Total assets | $12.41M | |
| Total current liabilities | $6.13M | |
| Current debt | $1.53M | |
| Long-term debt | $8.60M | |
| Total debt | $10.77M | |
| Total liabilities | $15.47M | |
| Retained earnings | -$91.50M | |
| Shareholder equity | -$3.05M | |
| Working capital | $5.26M | |
| Net tangible assets | -$3.05M | |
| Shares issued | 288.37M |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.38
-3.44% from price
SMA 20
0.38
-2.86% from price
SMA 50
0.40
-7.85% from price
SMA 100
0.45
-19.04% from price
SMA 200
0.50
-27.11% from price
EMA 12
0.38
-2.95% from price
EMA 26
0.38
-4.18% from price
EMA 50
0.40
-8.84% from price
RSI (14)
41.9
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.01
2.84% of price
Realised vol 30D
44.1%
Annualised
Bollinger upper
0.39
20, 2σ
Bollinger lower
0.36
20, 2σ
50 / 200 cross
Death
0.40 vs 0.50
Trend bias
Below 200
-27.11%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.52
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
44.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-50.4%
Peak to trough
Max drawdown 5Y
-79.0%
Peak to trough
ATR 14
0.01
2.84% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Mark Zuckerberg Published a 6,500-Word AI Manifesto This Week Defending Meta's Unrestricted AI Buildout. Here's Why Investors Should Care.
Motley Fool · 16m ago
South Korean survivor fights for workplace harassment 'justice'
AFP · 46m ago
Apple Cut Its Standard EU App Store Commission From 30% to 26%
Motley Fool · 53m ago
Amazon-Backed Anthropic Needs $1.2 Trillion in Revenue to Justify $2 Trillion Valuation, 'Dean of Valuation' Says
Benzinga · 1h ago
Gundir Announces Gundir365(TM) Postage Promise, Locking In Direct Mail Postage Rates for a Full Year
ACCESS Newswire · 1h ago
Why Keysight Technologies Stock Sank This Week
Motley Fool · 1h ago
Sydney marathon unveils medal with wrong stadium
AFP · 1h ago
Atlassian (TEAM) Stock Looks Near Fair Value After Its 98% Run
Simply Wall St. · 1h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.